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Background:  Obesity is increasing globally across all population groups. Limited 
data is available on how obesity patterns differ across countries.  
Objective:  To document the prevalence of obesity and related health conditions 
for Europeans aged 50 and above, and estimate the association between obesity and 
health outcomes across 10 European countries. 
Methods:  Data were from the 2004 Survey of Health, Ageing and Retirement in 
Europe, a cross-national survey of 22,777 Continental Europeans over the age of 50. The 
health outcomes included self-reported health, disability, doctor-diagnosed chronic health 
conditions, and depression. Multivariate regression analysis was used to predict health 
outcomes across weight classes (defined by body mass index (BMI) from self-reported 
weight and height) in the pooled sample and individually in each country. 
Results:  The prevalence of obesity (BMI>=30) ranged from 12.8% in Sweden to 
20.2% in Spain for men and from 12.1% in Switzerland to 25.5% in Spain for women. 
Adjusting for compositional differences across countries changed little in the observed 
large heterogeneity in obesity rates throughout Europe. Compared with normal weight 
individuals, men and women with greater BMI had significantly higher risks for all 
chronic health conditions examined except heart disease in overweight men. Depression 
was linked to obesity in women only. Particularly pronounced risks of impaired health 
and chronic health conditions were found among the severely obese. The effects of 
obesity on health did not vary significantly across countries. 
Conclusions:  Cross-country differences in the prevalence of obesity in older 
Europeans are substantial and exceed socio-demographic differentials in excessive body   3
weight. Obesity is associated with significantly poorer health outcomes among Europeans 
aged 50 and above with effects similar across countries. Large heterogeneity in obesity 
throughout Europe should be investigated further to identify areas for effective public 
policy. 
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Introduction 
 
Over the last several decades, obesity has been increasing worldwide in virtually 
all population groups.
1-6  The growth in the population fraction with unhealthy body 
weight was particularly high in the U.S., although it has reached worrisome proportions 
in other developed and developing countries as well.
7 About two-thirds of U.S. adults 
aged 20 years and older is now either overweight or obese (defined as having a body 
mass index (BMI) of 25 kg/m
2 and above)
 and about 30% are obese (BMI>30 kg/m
2).
2 
On the global scale, more than one billion adults are estimated to be overweight with at 
least 300 million of them qualifying as obese.
7 High prevalence of overweight among 
children is another disturbing trend in countries throughout the world.
5, 8-11 
This study examines the relationship between obesity, general health, disability 
and chronic health conditions in older Europeans. The link between excessive body 
weight and health is an important concern for public health policy because obesity has 
considerable implications for morbidity and quality of life of obese individuals, and an 
attendant increase in health care costs. Obesity is an established risk factor for many 
highly-prevalent, mortality-driving and costly diseases, such as cardiovascular disease, 
diabetes and some types of cancer.
7, 12-14 Through poorer health and disability, it increases 
the financial burden of public transfer programs and private health plans. The costs are 
large. At the individual level, obesity is related to health care expenditures that are on 
average about one-third above medical costs of otherwise similar individuals with normal 
weight.
15-16 This exceeds the effect of smoking or problem drinking on health care 
costs.
15 At the aggregate level, obesity accounts for about 6-10% of national health care 
spending in the U.S.
 17-18  and 2.0-3.5% in other developed countries.
19-22  The rising   5
trends in obesity can explain 27% of the growth in real health care spending over 1987-
2001.
23  
The focus of this research is on adults aged 50 and older. For a number of reasons 
- the biology of aging, age-related changes in physical activity and calorie consumption - 
the health effects of obesity probably vary over the life cycle. For example, they are more 
likely to develop in middle age.
14 Therefore, generalizations from the overall population 
may be inaccurate for predicting health consequences of obesity in older adults. At the 
same time, understanding the effects of obesity on health and related outcomes among 
middle age individuals and the elderly is important because this population will be a 
long-time beneficiary of public programs that already pay for approximately half of 
medical expenditures attributable to overweight and obesity in the U.S.
16  The available 
data on obesity implications for mortality and morbidity among older adults is 
inconclusive, particularly for longevity among the obese elderly.
24-27 This study can help 
more accurately predict the health risks of obesity at older ages that would be of interest 
to public and private health plans. 
This analysis is one of few to apply a cross-national perspective to the study of 
obesity risks, and the first to do so for older adults. Despite the potential of comparative 
analysis to learn from institutional, cultural and socio-demographic differences across 
nations, multinational comparisons of obesity remain scarce. The best-known cross-
national estimates of obesity to date are studies among children,
8-11 and data from the 
World Health Organization MONICA (Multinational MONItoring of trends and 
determinants in CArdiovascular disease) project in 21 countries for 25-64-year old 
adults.
28-31 Recent additions to empirical research on obesity in Europe are cross-national   6
comparisons of obesity in adults aged 15-75 using data from the European Community 
Household Panel for nine EU member states
32 and estimates for the adult population (age 
15+) in 15 EU countries.
33 
In this paper we used data from the 2004 Survey of Health, Ageing and 
Retirement in Europe (SHARE) to document the prevalence of obesity and related 
chronic health conditions in the population ages 50 and above in 10 European countries. 
We examined the association between obesity, major chronic illnesses, self-reported 
health and disability, and studied whether it varied across the SHARE countries. We 
evaluated whether differences in the socio-demographic composition of the countries 
could explain large heterogeneity in the prevalence of obesity among older Europeans.  
 
 
Data and Methods 
 
The data come from the Survey of Health, Ageing and Retirement in Europe 
(SHARE), which collected information on nationally representative samples of the 
community-based population ages 50 and older in Continental Europe. The baseline 2004 
SHARE study included data on 11 countries that featured a balanced representation of the 
different European regions from Scandinavia (Denmark and Sweden) through Central 
Europe (Austria, France, Germany, Switzerland, Belgium, The Netherlands) to the 
Mediterranean (Spain, Italy and Greece). This study used data from the 2004 SHARE 
sample (Release 1 of April 28th, 2005) that included all participating countries with the 
exception of Belgium.  
The key advantage of this cross-national data is that it provides nationally 
comparable information on Europeans over the age of 50 and their spouses that was   7
collected in all countries following a standard protocol and research design. SHARE also 
contains detailed information on many different aspects of older individuals’ lives that 
few other large data sets have. These include health (e.g., self-reported health, grip 
strength, physical and cognitive functioning, health behaviors, health care use), 
psychological conditions (e.g., mental health, well-being, life satisfaction), socio-
economic status (e.g., work activity, job characteristics, wealth and consumption, 
housing, education), and social support (e.g., social networks, volunteer activities). 
Designed after the role models of the U.S. Health and Retirement Study (HRS) and the 
English Longitudinal Study of Ageing (ELSA), SHARE will be collecting data on older 
individuals over time. This paper uses data from the first wave in 2004. The longitudinal 
aspect of SHARE will be valuable for research as more waves become available. 
The survey was administered as computer assisted personal interviewing (CAPI) 
in the fall of 2004 among participants drawn from probability samples in all participating 
countries. The sampling plan followed a complex probabilistic multistage design to 
produce estimates representative of the non-institutionalized population aged 50 and 
above in each country. The study also interviewed spouses younger than 50. The 
response rate varied by country but on average was 57% for households and 86% for 
individuals within participating households.
34 A detailed description of the SHARE data 
and methodology was published elsewhere.
35 The data is available to registered users 
from the SHARE website (http://www.share-project.org). 
The 2004 SHARE Release I sample included 22,777 respondents from 10 
European countries. We imposed several sample restrictions. First, we excluded 
individuals younger than the age of 50 (759 observations or 3.3% of the original sample).   8
The second exclusion (1009 observations or 4.4% of the original sample) was for data 
with missing responses on predictors and key outcomes. Due to these selections 21,009 
individuals remained eligible for the analysis (9,652 men and 11,357 women).  
We compared the estimates of obesity in older adults in SHARE with attendant 
statistics for the general population from the WHO and the International Obesity 
TaskForce (IOTF). Although collected for a different age group than in SHARE, the data 
seem to accord well across sources, particularly for men. The correlation between 
average BMI per country in SHARE and estimates from the national surveys presented in 
the WHO Global InfoBase is 0.68 (p<0.05) for men and 0.43 for women. The correlation 
for obesity prevalence is 0.63 (p<0.05) for men and 0.52 for women in the WHO-SHARE 
comparisons, and correspondingly 0.61 (p<0.05) and 0.59 for the IOTF-SHARE. Perhaps 
reflecting cohort effects, obesity rates in older adults are notably above the general 
population prevalence in some countries, e.g. Spain (23% vs.15%). Still, the top five 
countries with high obesity rates in SHARE and IOTF are the same countries for women 




Health Outcomes: The vector of health outcomes is three-fold and includes self-
assessment of general health status and daily functioning, chronic health conditions, and 
emotional health. The measure of overall health is based on subjective evaluation of 
health by respondents, which they reveal in answering the survey question “Would you 
say your health is excellent, very good, good, fair, or poor?” Collapsing responses, we 
constructed an indicator for fair or poor self-reported general health vis-à-vis better   9
health. Disability evaluation was based on responses regarding limitations with activities 
of daily living (ADL) with at least one limitation indicating disability.   
Among the reported health ailments, we examined five chronic health conditions 
that have links with obesity in the literature. These are doctor-diagnosed chronic diseases, 
which are self-reported in the survey question: “Has a doctor ever told you that you have 
any of these conditions…” such as 1) diabetes or high blood sugar (the type of diabetes 
was not assessed); 2) cardiovascular disease (a heart attack, including myocardial 
infarction or coronary thrombosis or any other heart problem, including congestive heart 
failure), 3) high blood pressure or hypertension, 4) high blood cholesterol, and 5) 
arthritis, including osteoarthritis or rheumatism.” We constructed five indicators for these 
chronic illnesses. 
Finally, we used the depression scale EURO-D to evaluate how obesity is related 
to emotional health or depression. The EURO-D depression scale, validated in an earlier 
cross-European study
 39-40, was based on categorical responses about individual 
experiences of emotional problems in the month before the interview. The twelve 
feelings included sadness or depression, pessimism, suicidality, guilt, sleep trouble, 
interest, concentration, appetite, irritability, fatigue, enjoyment, and tearfulness.
 The 




Obesity:  The variable of primary interest was a measure of relative body weight. 
Individuals were classified into weight categories based on their BMI (weight in 
kilograms divided by the square of height in meters) calculated from self-reported weight   10
and height. This measurement approach is based on the clinical guidelines for the 
classification of overweight and obesity in adults, published by the National Heart, Lung 
and Blood Institute of the National Institutes of Health.
41 According to the NIH 
guidelines, individuals are stratified into six weight classes depending solely on their 
BMI: underweight (BMI<18.5), normal weight (BMI: 18.5-24.9), overweight (BMI: 
25.0-29.9), moderate obesity (BMI: 30.0-34.9), severe obesity (BMI: 35.0-40.0), and 
extreme obesity (BMI: 40.0+). Much of the empirical work on obesity focuses on the 
aggregate group of adults with a BMI of 30 and above, which is a likely result of the 
paucity of data on very high BMI or the convenience of generalizing results for all obese. 
We separated the obesity group (BMI LQWRPRGHUDWH%0,RI-34.9) and severe 
obesity (BMI  to account for non-linear effects of obesity on health. Prior research 
showed that severe obesity is associated with more chronic health problems than 
moderate obesity, and its onset is at earlier ages.
42 As a result, there are large differences 
across the obesity groups in health care utilization and costs.
43 The sample size of people 
with BMI was too small to enable meaningful estimation. 
Socio-demographic Covariates:  A variety of individual level variables were 
included as controls in the estimation. Socio-demographic covariates were presented by 
educational achievement (secondary and tertiary education, primary or no education is a 
reference group), marital status (married and living together with a spouse or registered 
partnership), household income (an inverse of a hyperbolic sine of annual household 
income before taxation), and age (five-year increment age groups up to the age of 85+). 
Current and past smoking was controlled in all models. We included country fixed effects 
in the estimation on the pooled sample of all countries. Interactions between weight   11
classes and country dummies were tested to compare the gradient of obesity and health 
across countries. 




We pooled the SHARE data across all countries and conducted all analyses 
separately for men and women. To account for the complex sampling design and obtain 
nationally representative estimates, we used individual sample weights when presenting 
sample statistics but not in regression analysis. The Huber/White nonparametric 
correction produced robust standard errors. We conducted statistical testing of differences 
between the national means and the sample average for all prevalence statistics. We used 
logistic regression to generate the odds ratio (ORs) for the association between weight 
classes and health outcomes. We replicated all regression analyses in the pooled sample 
and separately by country. We tested whether the observed cross-country differences in 
obesity were generated by socio-demographic variation across countries comparing the 
non-adjusted ORs (based on descriptive statistics) and adjusted ORs (based on results 
from multivariate logistic regression) for obesity across countries and population groups. 
We checked robustness of our results to the inclusion of physical activity. This exercise 




Patterns in Obesity and Related Health Outcomes 
   12
The prevalence of overweight and obesity in Europeans older 50 is high, 
particularly in some countries. On average, only a third of men (33.4%) qualify as normal 
weight, whereas more women (44.1%) are normal weight based on the standard BMI 
criteria. Among men with weight above normal, 13.3% are moderately obese and almost 
3% are severely obese. For women, the prevalence rate is similar for moderate obesity 
(13.5%) and slightly higher than in men for severe obesity (4.3%). The socio-
demographic profile of the BMI distribution is comparable to the patterns established in 
earlier studies and in the U.S. data, such as higher obesity rates among less educated and 
lower prevalence of obesity among current smokers (Table 1). 
The rates of unhealthy body weight vary substantially across European countries 
(Table 2). Spain has the highest prevalence of obesity among men (20.2%) and women 
(25.5%), and almost twice the rate of severe obesity among women than the sample 
average (7.4% vs. 4.3%, p<0.01). Men are least likely to qualify as moderately or 
severely obese in Sweden (12.8%) whereas for women this is true of Switzerland (12.3%, 
less than half of the obesity rate in Spain). Comparing the prevalence of normal weight 
men, the Nordic countries (Denmark and Sweden), the Netherlands and Switzerland have 
rates above the average (p<0.01). Normal weight women are more likely to live in the 
Nordic countries, Switzerland, France and less likely in Southern Europe (p<0.01). 
We tested whether the observed cross-country differences in the prevalence of 
obesity were driven by socio-demographic differences in the composition of the nations. 
Adjusting for age, education, marital status and smoking (based on a logistic regression 
for obesity defined by BMI>=30) did not reduce the magnitudes notably (results not 
presented). The largest change after the compositional adjustment was for obesity in   13
Spain relative to Switzerland. The unadjusted OR for men was 1.71, which the 
adjustment for socio-demographic covariates reduced to 1.43 (p<0.01). Similarly, the 
unadjusted OR for women in Spain relative to Switzerland was 2.57, which was reduced 
to 2.22 (p<0.01) after adjusting for socio-demographics. The unadjusted OR for women 
with the least education relative to the highest educational level was 2.19, which after 
adjusting for other individual characteristics and the country of residence grew to 2.21 
(p=0.73). The OR for the comparison of the least educated and the most educated men 
was 1.99 in the non-adjusted statistics and 2.31 in the regression framework (p<0.01).
2  
Cross-country differences in the prevalence of major chronic health conditions are 
substantial too (Table 3)
 3. Some of them may be related to the cross-country variation in 
obesity. For example, the prevalence of diabetes in Spain, the country with the highest 
obesity rates, is 14.3% for men and 13.1% for women. These rates are twice lower in 
Switzerland (7.2% men; 4.1% women), which is the country with the lowest obesity 
rates. The link to obesity is less apparent for some other chronic health conditions. 
Cholesterol levels are often high in France, but the prevalence of obesity is relatively low. 
Heart disease is most often reported in Sweden where obesity is not a prevalent 
condition. Cross-country differences in other risk factors and the socio-demographic 
composition of the population may account for the observed disparities in the rate of 
obesity and some chronic health conditions. For example, high rates of heart disease in 
Sweden most likely reflect an older sample in the country: the share of aged 75+ and 80+ 
Swedes is the highest in SHARE, whereas aging is a known factor of heart disease.  
                                                 
2 We tested the null hypothesis that the odds ratio was the same before and after adjusting for socio-
demographic covariates. This was done using a minimum distance test comparing the difference between 
the two estimates (Hausman J. Specification tests in econometrics. Econometrica. 1978;46:1251-71). 
3 See [44] for a SHARE-based analysis of the prevalence of health conditions and socio-economic status.   14
 
Relationship Between Obesity and Health Outcomes 
Regression analysis confirms descriptive results on obesity and health. As 
compared to normal weight people, men and women with BMI of 30 and above are 
significantly more likely to have adverse health outcomes like ADL-disability, major 
chronic health conditions and poor general health (Table 4). Severely obese women 
report poor or fair health status almost twice as often as women of normal weight (90%, 
p<0.01), which accords with estimates from earlier studies and the U.S. data.
13,45 Among 
men, the most prevalent adverse self-reports of health are predicted in the underweight 
group (106% vs. normal weight, p<0.01). The estimates for ADL-disability reveal a 
similar pattern of the least healthy men among the underweight and the least healthy 
women among the severely obese. Another gender-related difference in the effect of 
excessive body weight on health is that overweight men report poor health as often as 
normal weight men (30.2% vs. 30.1%), whereas overweight is a significant risk factor for 
poor self-reported health in women (38.8% vs. 33.8%, p<0.01). 
Both overweight and obesity are associated with chronic health conditions like 
diabetes, high blood cholesterol, hypertension and arthritis in men and women (Table 4). 
Compared to older women of normal weight, women with BMI of 30-34.9 are three times 
more likely to have diabetes and almost twice as likely to report hypertension. The effects 
for men are somewhat smaller, yet still substantial, for example, about 140% higher rates 
of diabetes and 96% of hypertension among moderately obese vs. normal weight men. 
Similar to earlier studies, this analysis reveals considerable differences in health risks 
related to excessive body weight by degree of obesity.
13-14, 43,45  Individuals with BMI   15
35 kg/m
2 have notably higher odds than obese people with BMI of 30-34.9 kg/m
2 for all 
examined chronic conditions but heart disease in men, poor health and ADL-disability. 
The interactions between country indicators and weight groups (in different specifications 
that we tried) were not statistically significant for all health measures.  
The results on the effects of obesity on health are robust to the inclusion of 
physical activity measures in estimations. Obesity is associated with significantly higher 
risks of poor health, disability and chronic health diseases independent of physical 
inactivity, although obesity-related differences in adverse health outcomes decrease 
slightly in models that include physical activity controls. For example, an increase in the 
probability of poor health between normal weight and obese men is 19 percentage points, 
which declines by 2 percentage points with adjustment for vigorous and moderate 
activity. The same 1-3 percentage point reduction in the estimates of obesity holds for 
other health outcomes. Hence, the association of obesity with poor health does not appear 
to reflect the effect of physical inactivity but rather has a health effect independent of 




Obesity is a significant problem in older Europeans that already affects every 
eighth Swiss, every sixth German man, and every fourth woman in Spain. The 
compositional differences of the nations with rather distinct socio-demographic 
characteristics do not explain the observed large variation in obesity rates throughout 
Europe. In contrast, differences related to diet culture, physical activity and other lifestyle 
behaviors may be at play. Large differences in obesity prevalence across European   16
countries should be investigated further, as they are likely to suggest areas for effective 
public health policy. 
   Similar to studies in the general population, this analysis suggests that obesity is 
strongly associated with major health risks for older adults. The odds of disability, poor 
self-reported health and chronic health conditions are multi-fold for obese men and 
women as compared to normal weight people, and hold independently of the effects of 
physical inactivity on health. Particularly high risks of disability and impaired health are 
related to severe obesity in older people, especially women. 
The differences in how obesity is related to health outcomes across countries are 
not statistically significant in the interactions analysis. At the same time, the associated 
magnitudes with obesity and their variation for some conditions in the by-country 
analysis suggest the need for further exploration in this domain. Table 5 (for men) and 
Table 6 (for women) present results (adjusted odds ratio) from separate multivariate 
logistic models for the SHARE countries explaining the association between obesity and 
selected health outcomes. For example, Swiss men in poor health are about four times 
more likely to be obese than otherwise similar Swiss men. In Greece, the ratio is only 
1.35 and the difference between the obesity rate for otherwise similar men who are and 
are not in poor health is not significant.  
Furthermore, we found a significant link between obesity and heart disease among 
men in four out of the ten countries examined, with no apparent explanation of the 
differences related to the sample size of the countries or other obvious reasons (results 
not presented). The association between obesity and high cholesterol levels was not 
significant in countries like France that have traditionally cholesterol-rich diet and high   17
estimates of cholesterol blood levels. Obesity affected depression among women only in 
several countries (with no clear geographic or cultural pattern). Differences in the 
gradient between obesity and health across countries and their relation to institutional 
characteristics of the nations deserve further research.   
The current study has several limitations that may be overcome by future data 
collection. First, we only have self-reported height and weight. Several U.S. studies show 
that individuals with excessive body weight tend to underreport their weight (with an 
increasing extent among the more obese). In addition, respondents often overestimate 
height, particularly in older population groups.
 36-38 The estimates based on subjective 
assessment of body weight and height are likely to underestimate the actual prevalence of 
obesity in the participating SHARE countries. If the tendency to systematically under- or 
over-report varies across countries, this could hamper our cross-country comparison. To 
test this hypothesis, we would need objective measurements in the SHARE countries. 
Second, undiagnosed chronic diseases could not be counted. Given the differences in 
health care systems across the SHARE countries, the prevalence of specific chronic 
health conditions might be underestimated more in some countries than in others. Third, 
we have relatively small samples and low response rates in some countries, particularly 
Switzerland. Finally, the survey does not cover the institutionalized population. 
Nevertheless, the study provides evidence that obesity has significant implications 
for increased morbidity of older adults observed across all population groups and 
countries examined. Public and private health plans are recommended to consider the 
risks of excessive body weight for their beneficiaries that are likely to persist well into 
old age. Prevention of weight gain is critical to older adults as well as in the general   18
population, particularly as effective obesity treatment has been a challenge thus far. Lack 
of success with long-term efficacy of many treatment therapies for obesity attests that the 
best long-term approach to the problem of obesity is prevention.
7,46-49  
Critical to obesity prevention is improving diet through reduced intakes of fat and 
added sugar and increasing physical activity levels, so that interventions focus on dietary 
behavior, physical activity or their combination. For older adults, preventive strategies 
like regular participation in physical activity of at least moderate intensity could be the 
first step in changing the energy balance. Moderate physical activity such as walking is 
available to older adults even with some health constraints, whereas even a small change 
in calorie expenditure due to increased physical activity is likely to help prevent weight 
gain in addition to overall health benefits of regular exercise. 
Overall, a number of preventive strategies could be initiated, although further 
research is necessary to understand the effectiveness and cost-effectiveness of different 
policies. For example, the initiatives to improve nutritional choices among consumers 
could include the provision of low-calorie or zero-calorie drink choices and a wider array 
of beverage sizes, reasonable meal portions, and flexible pricing mechanisms for low-
calorie food and beverage options. The mandatory provision of food labeling in away-
from-home food establishments has been discussed in many countries. Medical 
professionals could influence individual diet and physical activity choices through regular 
advice, like advocating reduced consumption of high fat/energy dense food and sugary 
drinks and increased levels of physical activity, especially among patients susceptible to 
weight gain.   19
The case for counteracting obesity is overwhelming, as demonstrated in this 
paper. Still, the obesity problem has yet to generate sufficient policy attention to enable 
changes in European countries, including those of particular need for reform. The rapid 
growth in obesity over the past decades and large differences in the prevalence of obesity 
across countries with similar populations indicate that trends in obesity are 
environmentally based, and the key causes for obesity spread are societal. Identifying 
programs that address these societal contributors to the epidemic of obesity should be 
public health priorities in European countries.   20
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Men, N = 9652 
Age             
   50-64 years  5180  0.2  32.4  50.9  13.3  3.1 
     >=65  4472  0.9  34.6  48.6  13.3  2.7 
Highest education           
Primary or 
less  4370  0.6  31.1  49.1  15.5  3.7 
     Secondary   3150  0.6  32.9  50.9  12.9  2.7 
     Tertiary  2132  0.0  39.1  49.7  9.5  1.6 
Marital status             
     Married/ 
     partnered   7879  0.3  32.7  50.5  13.8  2.7 
     Single/ 
     divorced  1773  0.9  35.6  47.8  11.9  3.7 
Smoking status           
     Current  2304  0.6  37.8  47.4  11.1  3.1 
Past    3913  0.5  29.3  51.9  15.0  3.3 
Never   3435  0.4  35.0  49.3  12.9  2.4 
Total  9652  0.5  33.4  49.8  13.3  2.9 
Women, N = 11,357 
Age, years             
     50-64  6088  1.5  45.3  35.2  13.2  4.8 
     >=65  5269  2.3  43.1  36.9  13.8  3.9 
Highest education           
Primary or 
less  6485  1.8  39.8  37.9  15.5  4.9 
     Secondary   3143  1.9  45.8  35.8  12.7  3.8 
     Tertiary  1729  2.5  58.8  28.9  6.8  2.9 
Marital status             
     Married/ 
     partnered   7290  1.4  43.5  37.3  13.7  4.1 
     Single/ 
     divorced  4067  2.5  44.8  34.7  13.4  4.6 
Smoking status           
     Current  1831  4.1  51.9  31.9  9.6  2.6 
Past  1997  2.2  44.8  35.1  13.1  4.8 
Never  7529  1.5  42.6  37.0  14.3  4.5 
Total  11357  1.9  44.1  36.1  13.5  4.3 
 
Note:  Estimates in parentheses are standard deviations.  
Data are presented as percentages. The reported estimates are weighted.   25



















Men, N = 9652 
Austria  798  0.3  29.8*  51.9  14.5  3.4 
Denmark  735  0.6  40.1**  45.3*  11.8  2.2 
France  734  0.6  36.0  48.3  12.3  2.8 
Germany  1352  0.4  31.7  50.9  14.0  2.9 
Greece   877  0.1*  28.6**  54.5*  14.5  2.3 
Italy  1106  0.6  34.1  50.1  12.4  2.8 
Netherlands  1314  0.3  38.1**  48.5  11.1*  1.9* 
Spain  937  0.6  29.2**  49.9  16.2*  4.0 
Sweden  1368  0.6  39.5**  47.1  10.4**  2.4 
Switzerland  431  0.4  39.9**  46.6  11.1  1.9 
Total  9652  0.5  33.4  49.8  13.3  2.9 
Women, N =11,357 
Austria  1069  1.5  43.4  35.4  15.9*  3.8 
Denmark  834  4.2**  51.5**  31.0**  10.9*  2.4** 
France  891  3.6**  51.2**  30.1**  11.2*  3.9 
Germany  1539  1.2*  43.6  37.8  13.2  4.2 
Greece   1033  0.9*  35.2**  41.9**  16.9**  5.0 
Italy  1347  2.3  44.3  36.4  13.7  3.4 
Netherlands  1436  1.4  46.1  36.0  12.1  4.4 
Spain  1218  0.5**  32.4**  41.5**  18.1**  7.5** 
Sweden  1524  2.2  49.5**  33.8  11.6*  2.8** 
Switzerland  466  3.4  55.3**  29.1**  9.4**  2.9 
Total  11357  1.9  44.1  36.1  13.5  4.3 
 
Note:  Estimates in parentheses are standard deviations. 
Data are presented as percentages. The reported estimates are weighted. 
 
* Significantly different from the sample mean at the 5% level. 
 ** Significantly different from the sample mean at the 1% level. 
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Table 3: Prevalence of Obesity-Related Health Outcomes by Country 
 
 
  Poor/fair self-
reported health 
ADL-
disability  Diabetes  High cholesterol  Hypertension  Arthritis  Heart disease  Depression 
  Men, N=9652  
Austria  27.7*  8.1  9.9  16.9  27.0*  7.9**  11.5  12.4** 
Denmark  24.0**  9.5  8.1**  17.4  30.7  19.4**  9.7**  13.9* 
France  31.1  12.8**  10.8  23.2**  26.9**  23.5**  17.0**  21.9** 
Germany  37.1**  8.3  11.0  18.1  33.5*  9.1**  13.5  12.6** 
Greece   25.2**  6.4**  8.6**  19.5  32.2  9.6**  14.9  12.8** 
Italy  32.3  9.7  12.6  17.3  36.6**  18.8**  11.4  23.4** 
Netherlands  25.4**  6.3**  7.8**  16.3**  22.5**  5.5**  13.4  15.8  
Spain  34.4  9.2  14.3**  22.9*  26.7**  18.8**  11.4  20.9* 
Sweden  10.6**  7.8  9.8  16.4**  27.6*  5.9**  20.1**  12.7** 
Switzerland  13.8**  4.4**  7.2**  15.7*  28.7  7.1**  8.5**  11.2** 
Total  31.7  9.3  11.3  19.4  30.9  14.9  13.5  17.8 
  Women, N=11357 
Austria  30.7**  11.5  8.1**  15.6**  34.3  13.4**  7.9  26.0** 
Denmark  25.3**  10.1  6.7**  13.7**  28.4**  32.5**  7.4*  21.6** 
France  35.4**  12.5  7.9**  25.9**  33.3  38.1**  10.5  42.5** 
Germany  42.4*  12.1  12.9**  18.8  38.2*  14.4**  10.1  27.4** 
Greece   36.6  11.5  8.9  22.1  41.1**  25.1  9.9  34.8 
Italy  45.6**  12.5  11.1  19.7  36.2  36.6**  8.0  40.5** 
Netherlands  28.6**  9.5*  8.7*  13.3**  27.6**  13.5**  8.1  25.4** 
Spain  47.6**  13.2  13.1*  25.0**  37.6  35.0**  10.6  46.1** 
Sweden  15.4**  11.7  7.8**  16.4**  29.4**  13.8**  14.6**  27.3** 
Switzerland  17.8**  8.3**  4.1**  9.8**  23.2**  14.8**  5.2**  23.1** 
Total  39.6  12.1  10.7  20.5  35.5  26.8  9.6  35.4 
 
Note: Data are presented as percentages. The reported estimates are weighted. 
* Significantly different from the sample mean at the 5% level.  ** Significantly different from the sample mean at the 1% level.   27
Table 4: Health Risks of Obesity in Men and Women Aged 50+ 
 
 
  Underweight 
BMI <18.5 









  Men, N=9652 
Poor or fair self-
reported health  4.41 (3.66)  1.00  0.99 (-0.09)  1.61 (6.14)  2.49 (6.29) 
ADL-disability  5.03 (3.92)  1.00  1.06 (0.67)  1.69 (4.42)  2.91 (5.48) 
Diabetes  2.15 (0.96)  1.00  1.56 (5.18)  2.74 (9.66)  4.19 (8.52) 
High cholesterol   0.56 (-0.93)  1.00  1.42 (5.62)  1.55 (5.09)  1.90 (4.15) 
Hypertension   0.59 (-1.12)  1.00  1.70 (9.88)  2.82 (13.87)  4.04 (9.79) 
Arthritis  1.22 (0.56)  1.00  1.21 (2.63)  1.57 (4.49)  1.82 (3.19) 
Heart disease  0.87 (-0.30)  1.00  1.12 (1.70)  1.57 (4.69)  1.56 (2.35) 
Depression  4.19 (3.89)  1.00  0.88 (-1.96)  1.08 (0.79)  1.48 (2.40) 
Number of 
observations  37  3270  4847  1245  253 
  Women, N=11,357 
Poor or fair self-
reported health  2.25 (5.18)  1.00  1.28 (4.93)  2.18 (11.85)  4.09 (13.42) 
ADL-disability  2.26 (4.08)  1.00  1.32 (3.49)  2.09 (7.54)  4.20 (10.64) 
Diabetes  0.62 (-1.21)  1.00  1.92 (7.54)  3.59 (12.80)  6.02 (13.54) 
High cholesterol   0.50 (-2.68)  1.00  1.25 (3.95)  1.41 (4.56)  1.43 (3.06) 
Hypertension   0.56 (-3.02)  1.00  1.82 (12.52)  2.71 (15.76)  4.65 (14.63) 
Arthritis  0.74 (-1.52)  1.00  1.22 (3.59)  1.69 (7.58)  2.34 (7.73) 
Heart disease  1.11 (0.43)  1.00  1.24 (2.68)  1.75 (5.63)  2.01 (4.48) 
Depression  1.39 (2.13)  1.00  1.07 (1.47)  1.37 (4.82)  1.99 (6.71) 
Number of 
observations  205  4965  4147  1562  478 
 
Note:  Data are presented as fully adjusted odds ratio (OR) with z-statistic in parentheses from multivariate 
logistic regression (age, education, marital status, smoking status, and country dummies included) 
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Table 5: Cross-Country Effects of Obesity on Health Among Men Aged 50+ 
 
 
Results from by-country analyses: adjusted odds ratio for obesity groups 
 
  
Poor self-reported health  ADL-disability  Diabetes 
















































































































































              
 
Note: ** Significantly different from normal weight in the country at 1% level; * at 5%; *^ at 10%. 
 
Presented results are odds ratio from multivariate regression logistic models estimated for each country 
individually. Standard errors are in parentheses. 
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Table 6: Cross-Country Effects of Obesity on Health Among Women Aged 50+ 
 
 




health  ADL-disability  Diabetes 
  BMI 30-35  BMI 35+  BMI 30-35  BMI 35+  BMI 30-35  BMI 35+ 



































































































































Note: ** Significantly different from normal weight in the country at 1% level; * at 5%; *^ at 10%. 
 
Presented results are odds ratio from multivariate regression logistic models estimated for each country 
individually. Standard errors are in parentheses.   30
Appendix  
 





Ages 50+, SHARE 2004    General population, IOTF* 
  Men  Women  All    Men  Women  Ages  Period 
Austria  17.9  19.7  18.9    10.0  14.0  25--64  1999 
Denmark  14.0  13.2  13.6    12.5  11.3  30--60  1992 
France  15.0  15.1  15.1    11.4  11.3  15+  2003 
Germany  16.9  17.4  17.2    22.5  23.3  25+  2002 
Greece  16.8  21.9  19.5    20.0  15.0  20--89  2001-02 
Italy  15.3  17.1  16.3    9.3  8.7  18+  2003 
Netherlands  13.1  16.5  14.9    10.4  10.1  20--59  1998-02 
Spain  20.3  25.6  23.1    13.4  15.8  25--60  1990-00 
Sweden  12.8  14.4  13.6    14.8  11.0  25--64  2002 
Switzerland  12.9  12.2  12.5    14.1  10.4  35--74  2000-01 
US  22.3  23.8  23.1    31.1  33.2  20--74  2003-04 
 
*International Obesity Taskforce, Source: 
http://www.iotf.org/database/GlobalAdultsAugust2005.asp 
  
 